Literature DB >> 16441481

HLA-G levels in serum and plasma.

N Rudstein-Svetlicky1, R Loewenthal, V Horejsi, E Gazit.   

Abstract

HLA-G belongs to the non-classical HLA class-I family of genes presently designated as class-Ib genes. There are four membrane-bound (HLA-G1 to -G4) and three soluble forms (HLA-G5 to -G7) generated by alternative splicing of the primary transcript. HLA-G in the soluble form is found in the plasma, amniotic fluid, and cord blood of healthy individuals. Quantitative determination suggested that HLA-G levels are genetically controlled. While quantifying soluble HLA-G by ELISA, we observed that when plasma and serum levels were measured for the same individual, HLA-G plasma values were almost invariably higher than those from serum. Our results suggest that HLA-G is trapped and/or consumed during clot formation. The amount trapped within the clot is variable and inconsistent. To obtain values which reflect the true biological levels, it is therefore recommended that HLA-G should be determined in the plasma. If serum levels are determined, they should be compared with matched control sera. It should always be borne in mind that conclusions concerning sera levels might be erroneous, because the true plasma level of the protein can be significantly higher.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441481     DOI: 10.1111/j.1399-0039.2006.00540.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  12 in total

1.  Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.

Authors:  Inès Zidi; Olfa Dziri; Nour Zidi; Refaat Sebai; Nadia Boujelebene; Amna Ben Hassine; Hamza Ben Yahia; Ahmed Baligh Laaribi; Wafa Babay; Hela Rifi; Amel Mezlini; Hanene Chelbi
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

2.  Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis.

Authors:  P Contini; S Negrini; G Murdaca; M Borro; F Puppo
Journal:  Clin Exp Immunol       Date:  2018-05-23       Impact factor: 4.330

Review 3.  Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.

Authors:  Marica Garziera; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

4.  Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Cristiano Jodicke; Shali Mazaki-Tovi; Edi Vaisbuch; Offer Erez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Sam S Edwin; Percy Pacora; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-12

5.  Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients.

Authors:  Jiaxi Chen; Bo Shen; Yufei Jiang; Li Jun; Ming Zhu; Baoguo Chen; Chibo Liu
Journal:  Clin Exp Med       Date:  2012-05-06       Impact factor: 3.984

6.  Pregnancy and breastfeeding: a new theory for sHLA-G in breast cancer patients?

Authors:  Inès Zidi; Najla Kharrat; Refaat Sebai; Nour Zidi; Hamza Ben Yahia; Aicha Bouaziz; Hela Rifi; Amel Mezlini; Roberta Rizzo
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

7.  TGF-β induces HLA-G expression through inhibiting miR-152 in gastric cancer cells.

Authors:  Zhongzheng Guan; Bingtan Song; Fengjun Liu; Dong Sun; Kexin Wang; Hui Qu
Journal:  J Biomed Sci       Date:  2015-12-02       Impact factor: 8.410

8.  Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.

Authors:  A Lin; C-C Zhu; H-X Chen; B-F Chen; X Zhang; J-G Zhang; Q Wang; W-J Zhou; W Hu; H-H Yang; H-H Xu; W-H Yan
Journal:  J Cell Mol Med       Date:  2010-09       Impact factor: 5.310

Review 9.  HLA-G Neo-Expression on Tumors.

Authors:  Maria Loustau; François Anna; Raphaelle Dréan; Martin Lecomte; Pierre Langlade-Demoyen; Julien Caumartin
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

Review 10.  The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design.

Authors:  Amy L Kessler; Marco J Bruno; Sonja I Buschow
Journal:  Vaccines (Basel)       Date:  2020-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.